ADXN - addextherapeutics.com Uzoq muddatli majburiyatlarning kapitalga nisbati
Addex Therapeutics (ADXN) uchun ushbu kunlik narxlar grafigi aktivning dinamikasini aks ettiradi va uning qiymati 0.01 ni tashkil etadi. Addex Therapeutics toksiklikni kamaytirish uchun allosterik modulyatsiyadan foydalangan holda, epilepsiya va Parkinson kasalliklari uchun terapiyalarni ishlab chiqmoqda. Biznes kengaytiriladigan molekulalarni kashf qilish platformasiga tayanadi va yakuniy sinov xarajatlarini hamkorlar zimmasiga yuklaydi. Yuqori ilmiy nufuz va global ittifoqlar kompaniyaning neyrobiologiya sohasidagi yetakchilik maqomini tasdiqlaydi.
%3A%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_ADXN_-_Addex-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "ADXN: Addex Therapeutics Ltd Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 29.10.2026 | 👁️GURU.Markets👁️")
Addex Therapeutics (ADXN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Addex Therapeutics|ADXN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati addextherapeutics.com|ADXN - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Addex Therapeutics Ltd|ADXN - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzdorligi Addex Therapeutics
Kompaniyaning fundamental tahlili:ADXN, Addex Therapeutics Ltd.
Ushbu koeffitsiyent uzoq muddatli moliyalashtirishning kompaniya o'z kapitaliga bog'liqligini belgilaydi. U bir yildan ortiq qaytarish muddatiga ega bo'lgan qarz mablag'lari va aktivlarning bozor qiymati o'rtasidagi nomuvofiqlik xavfini o'lchaydi. Uzoq muddatli qarzdorlikning kapitalga nisbati trayektoriyasini tahlil qilish orqali investor biznesning moliyaviy barqarorligini baholaydi. Addex Therapeutics (ADXN) uchun ushbu muvozanat noyob allosterik modulatorlarni ishlab chiqishga investitsiya kiritishda juda muhimdir. Qarzni nazorat qilish kompaniyaga dori vositalarini bozorga chiqarishda narxlarni belgilash imkoniyatini taqdim etadi.
Addex Therapeutics raqobatchilari
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|acadia-pharm.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenon (XENE)|VKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SUPN|Catalyst Corp (CPRX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati harmonybiosciences.com|Uzoq muddatli qarzning kapitalga nisbati Biohaven BHVN|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Amylyx Pharmaceuticals Inc (AMLX)|TRVI - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Praxis Corp PRAX|AVXL (Anavex Life Sciences) - Uzoq muddatli qarzning kapitalga nisbati|ceribell.com (CBLL) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Prothena Corp|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Alector|ANNX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Omeros Corp. (OMER)|Uzoq muddatli qarzning o'z kapitaliga nisbati Neurogene Inc.|Uzoq muddatli kreditlarning kapitalga nisbati acimmune.com (ACIU)|Uzoq muddatli qarzning kapitalga nisbati Voyager Therapeutics, Inc.|Uzoq muddatli qarzning kapitalga koeffitsiyenti Neumora NMRA|SCLX (Scilex Holding Co.) - Uzoq muddatli qarzning kapitalga nisbati|TVGN: Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati alphacognition.com ACOG|cogrx.com (CGTX) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati SAVA|ASRT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati coyatherapeutics.com (COYA)|VTGN: Uzoq muddatli qarzning kapitalga nisbati|OVID - Uzoq muddatli majburiyatlarning kapitalga nisbati|Acumen Pharmaceuticals, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|CervoMed, Inc. (CRVO) - Uzoq muddatli qarzning kapitalga nisbati|ATHE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Clene (CLNN) - Uzoq muddatli kreditlarning kapitalga nisbati|PEPG: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati jupiterneurosciences.com|Uzoq muddatli qarzning kapitalga nisbati RLMD (Relmada Therapeutics, Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati ANVS (Annovis Bio Inc)|Uzoq muddatli qarzning o'z kapitaliga nisbati GRCE|Uzoq muddatli qarzdorlikning kapitalga nisbati Firefly Neuro AIFF|ANEW Medical, Inc. - Uzoq muddatli qarzning kapitalga nisbati|NRSN - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Reviva Pharmaceuticals Holdings, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi MetaVia|Uzoq muddatli qarzning o'z kapitaliga nisbati NeurAxis, Inc (NRXS)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi HSDT|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio, Inc. PASG|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NEUP (bionomics.com.au)|NERV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Athira Pharma Inc ATHA|ALZN (Alzamend) - Uzoq muddatli qarzning kapitalga nisbati|Cyclerion Therapeutics (CYCN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|PTIX: Uzoq muddatli qarzning o'z kapitaliga nisbati|KTTA (Pasithea Therapeutics Corp.) - Uzoq muddatli qarzning kapitalga nisbati|CRGT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ATXI|Brainstorm Cell Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cara Therapeutics Inc (CARA)|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati Eliem Therapeutics, Inc. ELYM|Intra-Cellular (ITCI) - Uzoq muddatli qarzning kapitalga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati Marinus|NKGen Biotech Corp (NKGN) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati NRBO (NeuroBo Pharmaceuticals)|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com (SAGE)|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix SNPX|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Trevena Inc. TRVN|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc.|WENA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Cerevel Therapeutics CERE